Implementation studies of ranibizumab for neovascular age‐related macular degeneration

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-3768|92|1|98-98

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.92, Iss.1, 2014-02, pp. : 98-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age‐related macular degeneration patients

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

One‐Year Effectiveness Study of Intravitreous Ranibizumab in Wet (Neovascular) Age‐Related Macular Degeneration: A Meta‐Analysis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 2, 2018-02 ,pp. : 197-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab

By Mitchell Paul  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1465-1475

Informa Healthcare

Access to resources Recommend Favorite

Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration

By Ngwa Wilfred   Makrigiorgos G Mike   Berbeco Ross I  

Physics in Medicine and Biology, Vol. 57, Iss. 20, 2012-10 ,pp. : 6371-6380

IOP Publishing

Access to resources Recommend Favorite

Burden of illness of bilateral neovascular age-related macular degeneration in Spain*

By María Ruiz-Moreno José   María Coco Rosa   García-Arumí José   Xu Xiao   Zlateva Gergana  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2103-2111

Informa Healthcare

Access to resources Recommend Favorite